During Brain Cancer Awareness month, let’s take the opportunity to delve into the fascinating world of nanomedicine. What is it, and what could it mean for kids with brain cancers like medulloblastoma?
May is Brain Cancer Awareness month. This is a great time to learn more about brain cancer, to help raise awareness of its importance and its impact, and to reflect on what we can do about it.
An exciting new field in medical research is opening up. Called metallomics, it centres on the role that metal elements in our bodies (iron, magnesium and the like) play in our health.
Tuesday 4 February 2020 is World Cancer Day and marks the midpoint of a 3-year campaign called ‘I am. I will.’ What does that mean? It means that every single one of us has a role to play in fighting cancer.
More effective treatment is needed for many childhood cancers, few more so than high-risk neuroblastoma, a very aggressive and difficult-to-treat tumour found in young children and babies which kills more than 50% of those diagnosed.
Thursday 26 September is the inaugural Childhood Brain Cancer Awareness Day. This year, we shine a light on Diffuse Intrinsic Pontine Glioma (DIPG), the most devastating of all childhood cancers.
Our researchers have discovered that a gene called JMJD6 plays an important role in the most aggressive form of neuroblastoma. What’s more, they’ve developed a targeted treatment against it.
Findings just published by our researchers reveal that anticancer drug CBL0137, previously shown to be active against many different cancers, is also highly effective against MLL-rearranged leukaemia, including the most common type of infant leukaemia.
In research published this week, scientists have found that a therapy originally developed to treat Alzheimer’s Disease could hold promise for children with T-cell acute lymphoblastic leukaemia.
Leukaemia is a cancer of the blood cells and bone marrow. In the case of acute myeloid leukaemia, it starts with a single cell known as a ‘leukaemia stem cell’. This cell is also thought to be responsible for relapse after treatment. So what do we know about it?